Evidence map›Paper›PMID 27412598›Full record

ArticleJournal of virology2016

High-Throughput Small Interfering RNA Screening Identifies Phosphatidylinositol 3-Kinase Class II Alpha as Important for Production of Human Cytomegalovirus Virions.

William S Polachek, Hanan F Moshrif, Michael Franti, Donald M Coen, Vattipally B Sreenu, Blair L Strang

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Structural basis of phosphatidylinositol 3-kinase C2α function.Nature structural & molecular biology · 2022
    Article
  3. An Overview of Class II Phosphoinositide 3-Kinases.Current topics in microbiology and immunology · 2022
    Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

William S PolachekDepartment of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Hanan F MoshrifInstitute of Infection & Immunity, St. George's, University of London, London, United Kingdom.
Michael FrantiBoehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut, USA.
Donald M CoenDepartment of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA.
Vattipally B SreenuMRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom.
Blair L StrangDepartment of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts, USA Institute of Infection & Immunity, St. George's, University of London, London, United Kingdom bstrang@sgul.ac.uk.
Harvard University · USSt George's, University of London · GBBoehringer Ingelheim (United States) · USMRC University of Glasgow Centre for Virus Research · GB

Funding

Human Cytomegalovirus Nuclear Egress: Molecular Mechanisms and Drug TargetingR01AI026077 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI COEN, DONALD M · 1999 to 2019
$10.9M
MOLECULAR GENETICS OF HSV DNA POLYMERASE GENER01AI019838 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI COEN, DONALD M, HOGLE, JAMES M · 1985 to 2015
$5.9M
Medical Research Council G0801822Medical Research Council MC_UU_12014/12NIAID NIH HHS R01 AI019838NIAID NIH HHS R01 AI026077
6 · The paper itself

Abstract

unlabelledHigh-throughput small interfering RNA (siRNA) screening is a useful methodology to identify cellular factors required for virus replication. Here we utilized a high-throughput siRNA screen based on detection of a viral antigen by microscopy to interrogate cellular protein kinases and phosphatases for their importance during human cytomegalovirus (HCMV) replication and identified the class II phosphatidylinositol 3-kinase class II alpha (PI3K-C2A) as being involved in HCMV replication. Confirming this observation, infected cells treated with either pooled or individual siRNAs targeting PI3K-C2A mRNA produced approximately 10-fold less infectious virus than the controls. Western blotting and quantitative PCR analysis of infected cells treated with siRNAs indicated that depletion of PI3K-C2A slightly reduced the accumulation of late but not immediate early or early viral antigens and had no appreciable effect on viral DNA synthesis. Analysis of siRNA-treated cells by electron microscopy and Western blotting indicated that PI3K-C2A was not required for the production of viral capsids but did lead to increased numbers of enveloped capsids in the cytoplasm that had undergone secondary envelopment and a reduction in the amount of viral particles exiting the cell. Therefore, PI3K-C2A is a factor important for HCMV replication and has a role in the production of HCMV virions. IMPORTANCE: There is limited information about the cellular factors required for human cytomegalovirus (HCMV) replication. Therefore, to identify proteins involved in HCMV replication, we developed a methodology to conduct a high-throughput siRNA screen of HCMV-infected cells. From our screening data, we focused our studies on the top hit from our screen, the lipid kinase phosphatidylinositol 3-kinase class II alpha (PI3K-C2A), as its role in HCMV replication was unknown. Interestingly, we found that PI3K-C2A is important for the production of HCMV virions and is involved in virion production after secondary envelopment of viral capsids, the encapsidation of HCMV capsids by a lipid bilayer that occurs before virions exit the cell.

Indexed as

Host-Pathogen InteractionsVirus ReplicationBlotting, WesternCells, CulturedCytomegalovirusFibroblastsGenetic TestingHigh-Throughput Screening AssaysHumansMicroscopy, ElectronPhosphatidylinositol 3-KinasesReal-Time Polymerase Chain ReactionRNA, Small InterferingPhosphatidylinositol 3-KinasesPIK3C2A protein, humanRNA, Small Interfering

Identifiers

PMID27412598
PMCPMC5008103
OpenAlexW2471963949

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.